RecruitingPhase 2Phase 3NCT03916978

Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women

Investigating Reactivation of Ovarian Function Following Autologous PRP Intra-ovarian Infusion in Menopausal Women

Sponsor

Genesis Athens Clinic

Enrollment

100 participants

Start Date

May 21, 2019

Study Type

INTERVENTIONAL

Conditions

Menopause Infertility, Female Amenorrhea Anovulatory Infertility

Summary

Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.

Eligibility

Sex: FEMALEMin Age: 45 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Autologous PFP intra ovarian infusion and a biological treatment called Autologous PRP intra ovarian infusion for people with amenorrhea, anovulatory infertility, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 45 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALAutologous PRP intra ovarian infusion

Autologous PRP intra ovarian infusion

BIOLOGICALAutologous PFP intra ovarian infusion

Autologous PFP intra ovarian infusion

Locations(1)

Genesis AC

Athens, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03916978

Related Trials

Menopausal HT for Women Living With HIV (HoT)

NCT0685617423 locations

Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function

NCT064901461 location